E-mail: bd@sidmexinovia.com
Telefone: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Jakavi 20 mg Tablet
Manufacturer/Marketed By : Novartis Healthcare Pvt Ltd
$526.56 $488.74
Jakavi 20 mg Tablet is a specialized medication classified as a Janus kinase inhibitor, designed to effectively treat intermediate to high-risk Myelofibrosis, a rare bone marrow cancer, as well as...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Ruxolitinib 20 mg
Active Pharmaceutical Ingredient
Jakavi 20 mg Tablet
US$ 526,56
US$ 488,74
Jakavi 20 mg Tablet is a specialized medication classified as a Janus kinase inhibitor, designed to effectively treat intermediate to high-risk Myelofibrosis, a rare bone marrow cancer, as well as Polycythemia Vera, a condition marked by excessive red blood cell production. By targeting specific pathways involved in these disorders, Jakavi helps to regulate blood cell formation and improve overall patient outcomes. Prior to starting treatment with Jakavi 20 mg, it is essential to conduct a blood cell count to ensure patient safety and monitor response to therapy. This medication is not suitable for children under 12 years, as its safety and efficacy in this age group have not been established. Patients should be aware of potential side effects and discuss any pre-existing conditions with their healthcare provider. By utilizing Jakavi, patients can experience a more stable blood profile and enhanced quality of life. Always consult a healthcare professional before initiating treatment to ensure it aligns with your health needs.
Active Pharmaceutical Ingredient
Usos
• Jakavi 20 mg tablet is primarily indicated for the treatment of polycythemia vera, a condition characterized by the overproduction of red blood cells. This medication helps to reduce the high red blood cell count, which can alleviate the symptoms associated with the disorder. By effectively managing the blood viscosity, Jakavi 20 mg tablet promotes better blood flow and reduces the risk of complications. Patients often experience an improvement in their overall health and well-being with this treatment.
• In cases where polycythemia vera is resistant to conventional therapies, Jakavi 20 mg tablet provides a valuable alternative. It works by targeting the underlying mechanisms of the disease, thereby helping to control the excessive production of red blood cells. This targeted approach can lead to a significant reduction in symptoms such as headaches, dizziness, and fatigue. Patients relying on Jakavi 20 mg tablet may find greater stability in their condition and enhanced quality of life.
• Jakavi 20 mg tablet is also utilized in managing the complications associated with polycythemia vera. By lowering the red blood cell count, this medication helps minimize the risk of thrombotic events, such as heart attacks or strokes. Patients taking Jakavi 20 mg tablet can feel more secure knowing they are actively reducing their risk factors. Regular monitoring while on this treatment allows healthcare providers to ensure optimal management of the condition.
• For individuals with polycythemia vera who experience severe symptoms, Jakavi 20 mg tablet can be an effective solution. It not only reduces the red blood cell levels but also addresses symptoms that can significantly impact daily life. The use of Jakavi 20 mg tablet can lead to a decrease in the frequency and severity of symptom flare-ups. As a result, patients may find it easier to engage in regular activities and maintain a more active lifestyle.
Benefícios
Jakavi 20 mg Tablet can be effective in reducing symptoms associated with myelofibrosis, such as fatigue, enlarged spleen, and uncontrolled bleeding
Jakavi 20 Tablet may improve the overall quality of life and reduce the symptoms of myelofibrosis.
Jakavi 20 mg Tablet has been shown to reduce bone marrow fibrosis (scarring) in those with myelofibrosis. Jakavi 20 mg Tablet prevent cancer in those with myelofibrosis and helps to prevent the progression of myelofibrosis to acute myeloid leukaemia (AML
Efeitos colaterais
Like all medicines, Jakavi 20 Tablet may have side effects. If you experience any, contacting your doctor or healthcare provider as soon as possible is important. They may be able to offer strategies to help manage or reduce the severity of these side effects.
Efeitos colaterais mais comuns
• Headache
• dizziness
• Weight gain
• High blood pressure
• High cholesterol
• Flatulence
• Abnormal liver function tests
• Difficulty in breathing
• Constipation
Efeitos colaterais comuns
• Decrease in red blood cells
• Infection
Como usar
You can take Jakavi 20 mg with or without food. Make sure that you take it at the same time of the day every day. Swallow the pill entirely with a drink of water. Do not crush, chew or open the tablet. If you miss a dose of this medicine, take it as soon as you remember to do so. Skip the missed dose and resume your regular dosing schedule if it's almost time for your next dose. To make up for a missed dose, do not take two doses at once.
Conselhos de segurança
• Alcohol: It's a good idea to avoid drinking alcohol while taking Jakavi 20 mg Tablet. Alcohol may increase the risk of side effects or decrease the effectiveness of Jakavi 20 mg. For your safety, consult your doctor or pharmacist before mixing alcohol with any medication.
• Kidney: Patients with kidney disease should use Jakavi 20 mg Tablet with caution. It's important for these patients to monitor their kidney function regularly while taking Jakavi 20 mg and to report any unusual symptoms or changes to their healthcare provider immediately. Dosage adjustments for Jakavi 20 Tablet may be necessary in individuals with kidney disease.
• Breastfeeding: Breastfeeding while using Jakavi 20 mg Tablet is generally not recommended as Jakavi 20 Tablet can pass into breast milk and potentially harm your baby. If you're currently breastfeeding and using Jakavi 20 mg, it's important to consult your doctor. They can discuss the potential risks and benefits with you and help you make the best choice for you and your baby.
• Liver: Patients with liver disease should use Jakavi 20 mg Tablet cautiously. It's important for these people to monitor their liver function regularly while using Jakavi 20 Tablet and to tell their doctor immediately of any unusual symptoms or changes. The dose of Jakavi 20 mg may need to be adjusted in people with liver disease.
• Pregnancy: Using Jakavi 20 mg Tablet during pregnancy may be risky as animal studies have shown that it may have adverse effects on the developing foetus. If you are pregnant or planning to become pregnant, it is important to discuss the potential risks and benefits of taking Jakavi 20 Tablet with your doctor. Your doctor can help you make the best decision for your health and the health of your baby.
• Driving: Using Jakavi 20 mg Tablet may cause dizziness, fatigue, and problems with concentration or coordination, which may affect your ability to drive safely. It's important to follow your doctor's advice and take the necessary precautions, such as not driving or operating heavy machinery, if you experience these side effects from Jakavi 20 Tablet.
Isenção de responsabilidade
A Sidmex Inovia se esforça para fornecer informações precisas e confiáveis; no entanto, todo o conteúdo deste site, incluindo descrições e composições de produtos, tem caráter meramente informativo e não deve ser considerado um substituto para aconselhamento, diagnóstico ou tratamento médico profissional.
Recomenda-se aos usuários que consultem um profissional de saúde qualificado antes de tomar qualquer decisão médica. As informações fornecidas não devem ser usadas para autodiagnóstico ou automedicação.
Todos os produtos listados destinam-se estritamente a consultas B2B e em grandes quantidades. A Sidmex Inovia não promove o uso direto pelo consumidor e visa apoiar, e não substituir, a relação entre o profissional de saúde e o paciente.
Os nomes de produtos, marcas comerciais e marcas pertencem aos seus respectivos proprietários, e seu uso não implica qualquer afiliação ou endosso. A Sidmex Inovia não se responsabiliza por quaisquer consequências decorrentes do uso das informações fornecidas neste site.